Our objective is to prevent the threat of new and reemerging ailments, and reduce the cases of sicknesses. Today, vaccines that reduce the probability of getting sick are only available to 55% of the Earth's population. We would like to develop a product that would be available to more people in all areas. We can use puraphage in aerosols, sanitizers, and introducing our product through injections. There are a lot of alternative medicine, but we could use an improved product that is more accessible. We want to protect our bodies from bacteria.
We can use bacteriophage to target bacteria like Campylobacter Jejuni. We will use Bacteriophage CP34. Bacteriophage CP34 is the specific bacteriophage that is going to be used to kill the Campylobacter Jejuni.
Because bacteriophage can work with bacteria like Campylobacter Jejuni, we believe it can work for other bacteria like Listeria Monocytogenes. With studies and tests, we can find a bacteriophage that works for Listeria Monocytogenes.